{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:39:13Z","timestamp":1793975953774,"version":"4.8.0"},"reference-count":142,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Abnormal protein glycosylation is a key feature of tumors. Among the modifications, Tn antigen (GalNAc\u03b11-Ser\/Thr) and its sialylated derivative, STn antigen (Neu5Ac\u03b12-6GalNAc\u03b11-O-Ser\/Thr), are prominent tumor-associated carbohydrate antigens. These antigens exhibit abnormal accumulation in epithelial malignancies, including colorectal cancer, breast cancer, and pancreatic cancer. Their pathological overexpression primarily stems from inactivation of the COSMC\/T-synthase axis, either due to genetic mutations or epigenetic silencing, leading to truncated O-glycan biosynthesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>Tn\/STn antigens directly promote tumor progression by activating oncogenic signaling pathways (e.g., EGFR\/FAK) and inducing epithelial-mesenchymal transition. Additionally, these antigens play a noticeable role in immune suppression in the tumor microenvironment. Tn antigens bind to macrophage galactose-specific lectin (MGL) on myeloid cells, while STn antigens interact with sialic acid-binding immunoglobulin-like lectins (Siglecs), collectively inhibiting natural killer cell cytotoxicity, dendritic cell maturation, and T cell activation. Changes in serum levels of glycoprotein tumor markers (e.g., CA15\u20133 and CA125) are associated with aberrant protein glycosylation in cancer cells, which may influence their expression levels, stability, or immunodetection. Current therapeutic approaches include monoclonal antibodies (e.g., Remab6, L2A5), antibody-drug conjugates, CAR-T cell therapies, and vaccines. However, challenges remain due to glycan heterogeneity and low immunogenicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Tn\/STn antigens play a pivotal role in tumorigenesis and immune evasion, presenting significant potential for both diagnostic and therapeutic applications. Future research should concentrate on elucidating the underlying mechanisms, developing innovative detection technologies, and promoting multidisciplinary collaborations to advance Tn\/STn antigen-based tumor molecular subtyping, precision targeted therapies, and efficacy prediction systems, thereby providing new directions for cancer diagnosis and treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1660852","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T06:31:43Z","timestamp":1764138703000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Tumor-associated Tn and STn antigens: from molecular mechanism to precision diagnosis and treatment"],"prefix":"10.3389","volume":"16","author":[{"given":"Shuailong","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cegang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boya","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruitao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huili","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-019-0129-4","article-title":"Glycosylation in health and disease","volume":"15","author":"Reily","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1034\/j.1600-065X.2000.917310.x","article-title":"Carbohydrate-mediated recognition systems in innate immunity","volume":"173","author":"Feizi","year":"2000","journal-title":"Immunol Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-440X(96)80036-4","article-title":"Carbohydrate recognition systems: functional triads in cell-cell interactions","volume":"6","author":"Crocker","year":"1996","journal-title":"Curr Opin Struct Biol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1649","article-title":"The sweet and sour of cancer: glycans as novel therapeutic targets","volume":"5","author":"Fuster","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/978-1-4615-1267-7_24","article-title":"Tumor-associated carbohydrate antigens defining tumor Malignancy: basis for development of anti-cancer vaccines","volume":"491","author":"Hakomori","year":"2001","journal-title":"Adv Exp Med Biol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1406619111","article-title":"Immature truncated O-glycophenotype of cancer directly induces oncogenic features","volume":"111","author":"Radhakrishnan","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109060200","article-title":"Cloning and expression of human core 1 beta1,3-galactosyltransferase","volume":"277","author":"Ju","year":"2002","journal-title":"J Biol Chem"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/prca.201300024","article-title":"Tn and sialyl-Tn antigens, aberrant O-glycomics as human disease markers","volume":"7","author":"Ju","year":"2013","journal-title":"Proteomics Clin Appl"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2016.03.008","article-title":"Short O-GalNAc glycans: regulation and role in tumor development and clinical perspectives","volume":"1860","author":"Chia","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"B10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/bs.acr.2014.11.002","article-title":"Simple sugars to complex disease\u2013mucin-type O-glycans in cancer","volume":"126","author":"Kudelka","year":"2015","journal-title":"Adv Cancer Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/bs.acr.2014.11.004","article-title":"Glycosylation characteristics of colorectal cancer","volume":"126","author":"Holst","year":"2015","journal-title":"Adv Cancer Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-021-01530-7","article-title":"Mapping of truncated O-glycans in cancers of epithelial and non-epithelial origin","volume":"125","author":"R\u00f8mer","year":"2021","journal-title":"Br J Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.13752","article-title":"Aberrant O-glycosylation contributes to tumorigenesis in human colorectal cancer","volume":"22","author":"Jiang","year":"2018","journal-title":"J Cell Mol Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-014-1799-5","article-title":"Cancer intelligence acquired (CIA): tumor glycosylation and sialylation codes dismantling antitumor defense","volume":"72","author":"Boligan","year":"2015","journal-title":"Cell Mol Life Sci CMLS"},{"key":"B15","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1146\/annurev-pathol-012414-040438","article-title":"Protein glycosylation in cancer","volume":"10","author":"Stowell","year":"2015","journal-title":"Annu Rev Pathol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3982","article-title":"Glycosylation in cancer: mechanisms and clinical implications","volume":"15","author":"Pinho","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"B17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1021\/acschemneuro.7b00271","article-title":"Glycosylation changes in brain cancer","volume":"9","author":"Veillon","year":"2018","journal-title":"ACS Chem Neurosci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00380","article-title":"Protein glycosylation and tumor microenvironment alterations driving cancer hallmarks","volume":"9","author":"Peixoto","year":"2019","journal-title":"Front Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2018.3","article-title":"The tumour glyco-code as a novel immune checkpoint for immunotherapy","volume":"18","author":"Rodr\u00cdguez","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2016.00054","article-title":"The sweet side of immune evasion: role of glycans in the mechanisms of cancer progression","volume":"6","author":"Nardy","year":"2016","journal-title":"Front Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2016.00109","article-title":"Turning-off signaling by siglecs, selectins, and galectins: chemical inhibition of glycan-dependent interactions in cancer","volume":"6","author":"Cagnoni","year":"2016","journal-title":"Front Oncol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13046-022-02335-z","article-title":"A roadmap for translational cancer glycoimmunology at single cell resolution","volume":"41","author":"Peixoto","year":"2022","journal-title":"J Exp Clin Cancer Res CR"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2100706","article-title":"Sweet immune checkpoint targets to enhance T cell therapy","volume":"208","author":"Derosiers","year":"2022","journal-title":"J Immunol Baltim Md 1950"},{"key":"B24","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2009.00767.x","article-title":"PD-1 signaling in primary T cells","volume":"229","author":"Riley","year":"2009","journal-title":"Immunol Rev"},{"key":"B26","doi-asserted-by":"publisher","first-page":"9532389","DOI":"10.1155\/2018\/9532389","article-title":"T-synthase deficiency enhances oncogenic features in human colorectal cancer cells via activation of epithelial-mesenchymal transition","volume":"2018","author":"Dong","year":"2018","journal-title":"BioMed Res Int"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.14117","article-title":"Tn antigen promotes human colorectal cancer metastasis via H-Ras mediated epithelial-mesenchymal transition activation","volume":"23","author":"Liu","year":"2019","journal-title":"J Cell Mol Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12943-015-0386-1","article-title":"COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer","volume":"14","author":"Hofmann","year":"2015","journal-title":"Mol Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70279","article-title":"Targeting tn antigen suppresses aberrant O-glycosylation-elicited metastasis in breast cancer","volume":"28","author":"Du","year":"2024","journal-title":"J Cell Mol Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/biom2040435","article-title":"Sialyl-tn in cancer: (how) did we miss the target","volume":"2","author":"Julien","year":"2012","journal-title":"Biomolecules"},{"key":"B31","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3390\/ijms17030275","article-title":"The role of sialyl-tn in cancer","volume":"17","author":"Munkley","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B32","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3390\/cancers16020240","article-title":"A comprehensive analysis of tn and STn antigen expression in esophageal adenocarcinoma","volume":"16","author":"Mercanoglu","year":"2024","journal-title":"Cancers"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64921-8","article-title":"Lectin histochemistry of resected adenocarcinoma of the lung: helix pomatia agglutinin binding is an independent prognostic factor","volume":"160","author":"Laack","year":"2002","journal-title":"Am J Pathol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1023\/A:1013879702702","article-title":"Carbohydrate expression profile of colorectal cancer cells is relevant to metastatic pattern and prognosis","volume":"19","author":"Konno","year":"2002","journal-title":"Clin Exp Metastasis"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201002313","article-title":"The Tn antigen-structural simplicity and biological complexity","volume":"50","author":"Ju","year":"2011","journal-title":"Angew Chem Int Ed Engl"},{"key":"B36","doi-asserted-by":"publisher","first-page":"108201","DOI":"10.1016\/j.biotechadv.2023.108201","article-title":"Modulating antibody effector functions by Fc glycoengineering","volume":"67","author":"Garc\u00eda-Alija","year":"2023","journal-title":"Biotechnol Adv"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1039\/D4SC01348D","article-title":"Highly stereoselective \u03b1-glycosylation with GalN3 donors enabled collective synthesis of mucin-related tumor associated carbohydrate antigens","volume":"15","author":"Shou","year":"2024","journal-title":"Chem Sci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2423943122","article-title":"CryoSeek II: Cryo-EM analysis of glycofibrils from freshwater reveals well-structured glycans coating linear tetrapeptide repeats","volume":"122","author":"Wang","year":"2025","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2417046121","article-title":"CryoSeek: A strategy for bioentity discovery using cryoelectron microscopy","volume":"121","author":"Wang","year":"2024","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B40","doi-asserted-by":"publisher","first-page":"4046","DOI":"10.1038\/s41467-023-39699-5","article-title":"Glycopeptide database search and de novo sequencing with PEAKS GlycanFinder enable highly sensitive glycoproteomics","volume":"14","author":"Sun","year":"2023","journal-title":"Nat Commun"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/chem.202501249","article-title":"Acceptor-adaptive automated glycosylation optimization for automated glycan assembly","volume":"31","author":"Bakhatan","year":"2025","journal-title":"Chem \u2013 Eur J"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1101\/2023.09.13.557529","article-title":"Deep quantitative glycoproteomics reveals gut microbiome induced remodeling of the brain glycoproteome","author":"Potel","year":"2023","journal-title":"BioRxiv - Mol Biol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/s41594-025-01485-w","article-title":"Uncovering protein glycosylation dynamics and heterogeneity using deep quantitative glycoprofiling (DQGlyco)","volume":"32","author":"Potel","year":"2025","journal-title":"Nat Struct Mol Biol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1389713","article-title":"Unraveling the role of C1GALT1 in abnormal glycosylation and colorectal cancer progression","volume":"14","author":"Tian","year":"2024","journal-title":"Front Oncol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.22545","article-title":"ST6GALNAC1 plays important roles in enhancing cancer stem phenotypes of colorectal cancer via the Akt pathway","volume":"8","author":"Ogawa","year":"2017","journal-title":"Oncotarget"},{"key":"B46","doi-asserted-by":"publisher","first-page":"BSR20220094","DOI":"10.1042\/BSR20220094","article-title":"O-glycosylation and its role in therapeutic proteins","volume":"42","author":"Thompson","year":"2022","journal-title":"Biosci Rep"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.3390\/biom12121732","article-title":"Emerging roles of the unique molecular chaperone cosmc in the regulation of health and disease","volume":"12","author":"Xiang","year":"2022","journal-title":"Biomolecules"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwr182","article-title":"Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family","volume":"22","author":"Bennett","year":"2012","journal-title":"Glycobiology"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.5.3.266","article-title":"The relation between polyagglutinability of erythrocytes in vivo and the H\u00fcbener-Thomsen-Friedenreich phenomenon","volume":"5","author":"Reepmaker","year":"1952","journal-title":"J Clin Pathol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3109\/08820138109093459","article-title":"The Thomsen-Friedenreich (TF) receptor: an old history with new mystery","volume":"10","author":"Uhlenbruck","year":"1981","journal-title":"Immunol Commun"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M205839200","article-title":"Molecular cloning and characterization of a novel UDP-Gal: GalNAc(alpha) peptide beta 1,3-galactosyltransferase (C1Gal-T2), an enzyme synthesizing a core 1 structure of O-glycan","volume":"277","author":"Kudo","year":"2002","journal-title":"J Biol Chem"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2005.04838.x","article-title":"Characterization of mucin-type core-1 beta1\u20133 galactosyltransferase homologous enzymes in Drosophila melanogaster","volume":"272","author":"M\u00fcller","year":"2005","journal-title":"FEBS J"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2007.04.045","article-title":"ER chaperones in mammalian development and human diseases","volume":"581","author":"Ni","year":"2007","journal-title":"FEBS Lett"},{"key":"B54","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3233\/CBM-130375","article-title":"The Cosmc connection to the Tn antigen in cancer","volume":"14","author":"Ju","year":"2014","journal-title":"Cancer biomark Sect Dis Markers"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-1921","article-title":"Role of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated sialyl-Tn antigen","volume":"64","author":"Marcos","year":"2004","journal-title":"Cancer Res"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/S0076-6879(10)79007-8","article-title":"Core 3-derived O-glycans are essential for intestinal mucus barrier function","volume":"479","author":"Xia","year":"2010","journal-title":"Methods Enzymol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20061929","article-title":"Increased susceptibility to colitis and colorectal tumors in mice lacking core 3-derived O-glycans","volume":"204","author":"An","year":"2007","journal-title":"J Exp Med"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1126\/science.1129200","article-title":"A mutant chaperone converts a wild-type protein into a tumor-specific antigen","volume":"314","author":"Schietinger","year":"2006","journal-title":"Science"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/s0925-4439(97)00090-2","article-title":"Repressed beta-1,3-galactosyltransferase in the Tn syndrome","volume":"1406","author":"Felner","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201003055","article-title":"Regulation of O-glycosylation through Golgi-to-ER relocation of initiation enzymes","volume":"189","author":"Gill","year":"2010","journal-title":"J Cell Biol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1093\/glycob\/cwj033","article-title":"ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity","volume":"16","author":"Julien","year":"2006","journal-title":"Glycobiology"},{"key":"B62","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2174\/1568009616666160922102641","article-title":"UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase- 6 (pp-galNAc-T6): role in cancer and prospects as a drug target","volume":"17","author":"Banford","year":"2017","journal-title":"Curr Cancer Drug Targets"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwi085","article-title":"Endoplasmic reticulum retention of the large splice variant of the UDP-galactose transporter is caused by a dilysine motif","volume":"15","author":"Kabuss","year":"2005","journal-title":"Glycobiology"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.277681","article-title":"Functional organization of Golgi N- and O-glycosylation pathways involves pH-dependent complex formation that is impaired in cancer cells","volume":"286","author":"Hassinen","year":"2011","journal-title":"J Biol Chem"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1172\/JCI186863","article-title":"ST6GalNAc-I regulates tumor cell sialylation via NECTIN2\/MUC5AC-mediated immunosuppression and angiogenesis in non-small cell lung cancer","volume":"135","author":"Appadurai","year":"2025","journal-title":"J Clin Invest"},{"key":"B66","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.3390\/cancers15133266","article-title":"Role of truncated O-galNAc glycans in cancer progression and metastasis in endocrine cancers","volume":"15","author":"Pinto","year":"2023","journal-title":"Cancers"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.2174\/1568009622666221010105701","article-title":"Up-regulation of core 1 beta 1, 3-galactosyltransferase suppresses osteosarcoma growth with induction of IFN-\u03b3 Secretion and proliferation of CD8+ T cells","volume":"23","author":"Tang","year":"2023","journal-title":"Curr Cancer Drug Targets"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1093496","article-title":"The (Sialyl) Tn antigen: Contributions to immunosuppression in gastrointestinal cancers","volume":"12","author":"Rajesh","year":"2022","journal-title":"Front Oncol"},{"key":"B69","article-title":"Structures common to different glycans","volume-title":"Essentials of glycobiology","author":"Stanley","year":"2022"},{"key":"B70","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/glycob\/cww086","article-title":"Biological roles of glycans","volume":"27","author":"Varki","year":"2017","journal-title":"Glycobiology"},{"key":"B71","article-title":"Essentials of glycobiology","year":"2022"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2006.05.022","article-title":"Differential regulation of C-type lectin expression on tolerogenic dendritic cell subsets","volume":"211","author":"van Vliet","year":"2006","journal-title":"Immunobiology"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxh246","article-title":"Carbohydrate profiling reveals a distinctive role for the C-type lectin MGL in the recognition of helminth parasites and tumor antigens by dendritic cells","volume":"17","author":"van Vliet","year":"2005","journal-title":"Int Immunol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwt021","article-title":"Tumor-associated Neu5Ac-Tn and Neu5Gc-Tn antigens bind to C-type lectin CLEC10A (CD301, MGL)","volume":"23","author":"Mortezai","year":"2013","journal-title":"Glycobiology"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125994","article-title":"The breast cancer-associated glycoforms of MUC1, MUC1-tn and sialyl-tn, are expressed in COSMC wild-type cells and bind the C-type lectin MGL","volume":"10","author":"Beatson","year":"2015","journal-title":"PLoS One"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-006-0274-z","article-title":"The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma","volume":"56","author":"Saeland","year":"2007","journal-title":"Cancer Immunol Immunother CII"},{"key":"B77","doi-asserted-by":"publisher","first-page":"547179","DOI":"10.1155\/2010\/547179","article-title":"Engagement of the mannose receptor by tumoral mucins activates an immune suppressive phenotype in human tumor-associated macrophages","volume":"2010","author":"Allavena","year":"2010","journal-title":"Clin Dev Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.9.5771","article-title":"IL-10: the master regulator of immunity to infection","volume":"180","author":"Couper","year":"2008","journal-title":"J Immunol Baltim Md 1950"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.1554","article-title":"Overexpression of MUC1 reconfigures the binding properties of tumor cells","volume":"94","author":"McDermott","year":"2001","journal-title":"Int J Cancer"},{"key":"B80","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrc1251","article-title":"Mucins in cancer: protection and control of the cell surface","volume":"4","author":"Hollingsworth","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.670396","article-title":"Mucin-1 protein is a prognostic marker for pancreatic ductal adenocarcinoma: results from the CONKO-001 study","volume":"11","author":"Striefler","year":"2021","journal-title":"Front Oncol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.12.029","article-title":"Isoforms of MUC16 activate oncogenic signaling through EGF receptors to enhance the progression of pancreatic cancer","volume":"29","author":"Thomas","year":"2021","journal-title":"Mol Ther J Am Soc Gene Ther"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-1035","article-title":"Tumor-associated Tn-MUC1 glycoform is internalized through the macrophage galactose-type C-type lectin and delivered to the HLA class I and II compartments in dendritic cells","volume":"67","author":"Napoletano","year":"2007","journal-title":"Cancer Res"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2003.025288","article-title":"High preoperative CA 15\u20133 concentrations predict adverse outcome in node-negative and node-positive breast cancer: study of 600 patients with histologically confirmed breast cancer","volume":"50","author":"Duffy","year":"2004","journal-title":"Clin Chem"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1177\/172460080001500410","article-title":"CA 15-3: a prognostic marker in breast cancer","volume":"15","author":"Duffy","year":"2000","journal-title":"Int J Biol Markers"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1984.254","article-title":"Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker","volume":"50","author":"Canney","year":"1984","journal-title":"Br J Cancer"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01622","article-title":"Tn antigen expression contributes to an immune suppressive microenvironment and drives tumor growth in colorectal cancer","volume":"10","author":"Cornelissen","year":"2020","journal-title":"Front Oncol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"9081","DOI":"10.3390\/ijms21239081","article-title":"Tn antigen expression defines an immune cold subset of mismatch-repair deficient colorectal cancer","volume":"21","author":"Matsumoto","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1012520","article-title":"MGL signaling augments TLR2-mediated responses for enhanced IL-10 and TNF-\u03b1 secretion","volume":"94","author":"van Vliet","year":"2013","journal-title":"J Leukoc Biol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.canlet.2021.06.012","article-title":"The Tn antigen promotes lung tumor growth by fostering immunosuppression and angiogenesis via interaction with Macrophage Galactose-type lectin 2 (MGL2)","volume":"518","author":"da Costa","year":"2021","journal-title":"Cancer Lett"},{"key":"B91","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s42003-021-02934-0","article-title":"Analysis of the glyco-code in pancreatic ductal adenocarcinoma identifies glycan-mediated immune regulatory circuits","volume":"5","author":"Rodriguez","year":"2022","journal-title":"Commun Biol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"e2119048119","DOI":"10.1073\/pnas.2119048119","article-title":"Antibody-mediated blockade for galectin-3 binding protein in tumor secretome abrogates PDAC metastasis","volume":"119","author":"Choi","year":"2022","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2023.10.024","article-title":"Hollow Cu2MoS4 nanoparticles loaded with immune checkpoint inhibitors reshape the tumor microenvironment to enhance immunotherapy for pancreatic cancer","volume":"173","author":"Yao","year":"2024","journal-title":"Acta Biomater"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-012-9653-8","article-title":"Knockdown of Core 1 Beta 1, 3-galactosyltransferase Prolongs Skin Allograft Survival with Induction of Galectin-1 Secretion and Suppression of CD8+T Cells: T synthase knockdown effects on galectin-1 and CD8+T cells","volume":"32","author":"Chen","year":"2012","journal-title":"J Clin Immunol"},{"key":"B95","article-title":"Mucins bearing the cancer-associated sialosyl-Tn antigen mediate inhibition of natural killer cell cytotoxicity","volume":"52","author":"Ogata","year":"1992","journal-title":"Cancer Res"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/nri3737","article-title":"Siglec-mediated regulation of immune cell function in disease","volume":"14","author":"Macauley","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1038\/s41467-021-21550-4","article-title":"Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9","volume":"12","author":"Rodriguez","year":"2021","journal-title":"Nat Commun"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02138","article-title":"Functional inhibitory siglec-6 is upregulated in human colorectal cancer-associated mast cells","volume":"9","author":"Yu","year":"2018","journal-title":"Front Immunol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/1476-4598-9-118","article-title":"Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes","volume":"9","author":"Belisle","year":"2010","journal-title":"Mol Cancer"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3552","article-title":"The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9","volume":"17","author":"Beatson","year":"2016","journal-title":"Nat Immunol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40164-021-00230-5","article-title":"Blocking siglec-10hi tumor-associated macrophages improves anti-tumor immunity and enhances immunotherapy for hepatocellular carcinoma","volume":"10","author":"Xiao","year":"2021","journal-title":"Exp Hematol Oncol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.01.026","article-title":"SIGLEC15 amplifies immunosuppressive properties of tumor-associated macrophages in pancreatic cancer","volume":"530","author":"Li","year":"2022","journal-title":"Cancer Lett"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2312929121","article-title":"Siglec-15\/sialic acid axis as a central glyco-immune checkpoint in breast cancer bone metastasis","volume":"121","author":"Wang","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0311212","article-title":"Differential expression of ST6GALNAC1 and ST6GALNAC2 and their clinical relevance to colorectal cancer progression","volume":"19","author":"Ahmad","year":"2024","journal-title":"PLoS One"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1111\/tan.12900","article-title":"Tumor-associated antigens: Tn antigen, sTn antigen, and T antigen","volume":"88","author":"Fu","year":"2016","journal-title":"HLA"},{"key":"B106","doi-asserted-by":"publisher","first-page":"450695","DOI":"10.1155\/2015\/450695","article-title":"MGL receptor and immunity: when the ligand can make the difference","volume":"2015","author":"Zizzari","year":"2015","journal-title":"J Immunol Res"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2211087120","article-title":"Germline C1GALT1C1 mutation causes a multisystem chaperonopathy","volume":"120","author":"Erger","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B108","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/bcr2577","article-title":"Tumour-associated carbohydrate antigens in breast cancer","volume":"12","author":"Cazet","year":"2010","journal-title":"Breast Cancer Res BCR"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3390\/biom5031783","article-title":"Challenges in antibody development against tn and sialyl-tn antigens","volume":"5","author":"Loureiro","year":"2015","journal-title":"Biomolecules"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2010-0307","article-title":"Phase III multicenter clinical trial of the sialyl-TN (STn)-keyhole limpet hemocyanin (KLH) vaccine for metastatic breast cancer","volume":"16","author":"Miles","year":"2011","journal-title":"Oncologist"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1080\/17435889.2024.2405454","article-title":"Detection of Tn-antigen in breast and prostate cancer models by VVL-labeled red dye-doped nanoparticles","volume":"19","author":"Verhassel","year":"2024","journal-title":"Nanomed"},{"key":"B112","article-title":"Radioiodinated anti\u2013TAG-72 non-covalently linked CC49 divalent single-chain Fv antibody","volume-title":"Molecular Imaging and Contrast Agent Database (MICAD)","author":"Cheng","year":"2004"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1134\/S0006297920090060","article-title":"CD44-associated tn antigen as a new biomarker of tumor cells with aberrant glycosylation","volume":"85","author":"Shuvalova","year":"2020","journal-title":"Biochem Biokhimiia"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1021\/acschembio.7b00471","article-title":"GalNAc-tyrosine is a ligand of plant lectins, antibodies, and human and murine macrophage galactose-type lectins","volume":"12","author":"Gibadullin","year":"2017","journal-title":"ACS Chem Biol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"100006","DOI":"10.1016\/j.glycos.2025.100006","article-title":"A cancer vaccine based on N-linked sialyl-Tn antigen elicits robust and selective antitumor immunity","volume":"1","author":"Huo","year":"2025","journal-title":"Glycosci Ther"},{"key":"B116","doi-asserted-by":"publisher","first-page":"9845123","DOI":"10.1155\/2018\/9845123","article-title":"Assessment of seven clinical tumor markers in diagnosis of non-small-cell lung cancer","volume":"2018","author":"Chen","year":"2018","journal-title":"Dis Markers"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1089\/hyb.1990.9.389","article-title":"Production of a monoclonal antibody as immunohistochemical marker on paraffin embedded tissues using a new immunization method","volume":"9","author":"Pancino","year":"1990","journal-title":"Hybridoma"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(90)90488-9","article-title":"A monoclonal antibody directed to Tn antigen","volume":"170","author":"Numata","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"B119","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/glycob\/cwj044","article-title":"Chemoenzymatically synthesized multimeric Tn\/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance","volume":"16","author":"S\u00f8rensen","year":"2006","journal-title":"Glycobiology"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/glycob\/cwaa044","article-title":"Erratum to: Identification of Tn antigen O-GalNAc-expressing glycoproteins in human carcinomas using novel anti-Tn recombinant antibodies","volume":"30","author":"Matsumoto","year":"2020","journal-title":"Glycobiology"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwz004","article-title":"A strategy for generating cancer-specific monoclonal antibodies to aberrant O-glycoproteins: identification of a novel dysadherin-Tn antibody","volume":"29","author":"Steentoft","year":"2019","journal-title":"Glycobiology"},{"key":"B122","article-title":"Phase I Study Of Interferon Enhanced Intraperitoneal Radioimmuno-Chemotherapy For Ovarian Cancer","year":"2013"},{"key":"B123","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1124\/jpet.118.255372","article-title":"A polymeric nanogel-based treatment regimen for enhanced efficacy and sequential administration of synergistic drug combination in pancreatic cancer","volume":"370","author":"Soni","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30445-9","article-title":"Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study","volume":"21","author":"Marabelle","year":"2020","journal-title":"Lancet Oncol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"100447","DOI":"10.1016\/j.esmoop.2022.100447","article-title":"Safety and preliminary activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody gatipotuzumab with the anti-EGFR tomuzotuximab in patients with refractory solid tumors","volume":"7","author":"Ochsenreither","year":"2022","journal-title":"ESMO Open"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.3c12487","article-title":"Targeted and self-adjuvated nanoglycovaccine candidate for cancer immunotherapy","volume":"18","author":"Freitas","year":"2024","journal-title":"ACS Nano"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwad035","article-title":"Targeting altered glycosylation in secreted tumor glycoproteins for broad cancer detection","volume":"33","author":"Kudelka","year":"2023","journal-title":"Glycobiology"},{"key":"B128","doi-asserted-by":"publisher","first-page":"5027","DOI":"10.1038\/s41598-023-31195-6","article-title":"Targeting Tn-positive tumors with an afucosylated recombinant anti-Tn IgG","volume":"13","author":"Matsumoto","year":"2023","journal-title":"Sci Rep"},{"key":"B129","doi-asserted-by":"publisher","first-page":"129513","DOI":"10.1016\/j.bbagen.2020.129513","article-title":"Characterization of Macrophage Galactose-type Lectin (MGL) ligands in colorectal cancer cell lines","volume":"1864","author":"Pirro","year":"2020","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"B130","doi-asserted-by":"publisher","first-page":"3536","DOI":"10.3390\/cancers15143536","article-title":"Aberrant glycosylation as immune therapeutic targets for solid tumors","volume":"15","author":"Matsumoto","year":"2023","journal-title":"Cancers"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1021\/jacsau.4c00921","article-title":"Decoding the molecular basis of the specificity of an anti-sTn antibody","volume":"5","author":"Soares","year":"2025","journal-title":"JACS Au"},{"key":"B132","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.3390\/ijms26073070","article-title":"Advancing non-invasive colorectal cancer screening: exploring the potential of monoclonal antibody L2A5","volume":"26","author":"Caldevilla","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B133","article-title":"Adoptive Immunotherapy for Advanced MUC1* Positive Breast Cancer With Autologous T Cells Engineered to Express a Chimeric Antigen Receptor, huMNC2-CAR44 or huMNC2-CAR22, Specific for a Cleaved Form of MUC1 (MUC1*)","year":"2023"},{"key":"B134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41589-025-01971-8","article-title":"Structure-guided phage display discovery of antibodies for (S)Tn-glycans in protein context","author":"Hurtado-Guerrero","year":"2025","journal-title":"Nat Chem Biol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"102350","DOI":"10.1016\/j.xcrm.2025.102350","article-title":"Pan-carcinoma sialyl-Tn-targeting expands CAR therapy to solid tumors","volume":"6","author":"Abrantes","year":"2025","journal-title":"Cell Rep Med"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.74.7.3023","article-title":"Isoantigenic expression of Forssman glycolipid in human gastric and colonic mucosa: its possible identity with \u2018A-like antigen\u2019 in human cancer","volume":"74","author":"Hakomori","year":"1977","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B137","article-title":"Expression of Forssman antigen synthesis and degradation in human lung cancer","volume":"67","author":"Taniguchi","year":"1981","journal-title":"J Natl Cancer Inst"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M114.039693","article-title":"Identification of distinct glycoforms of IgA1 in plasma from patients with immunoglobulin A (IgA) nephropathy and healthy individuals","volume":"13","author":"Lehoux","year":"2014","journal-title":"Mol Cell Proteomics MCP"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-021-00883-8","article-title":"IgA glycosylation and immune complex formation in IgAN","volume":"43","author":"Suzuki","year":"2021","journal-title":"Semin Immunopathol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abm8783","article-title":"Identification and characterization of circulating immune complexes in IgA nephropathy","volume":"8","author":"Matsumoto","year":"2022","journal-title":"Sci Adv"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.4c03632","article-title":"A versatile one-step enzymatic strategy for efficient imaging and mapping of tumor-associated tn antigen","volume":"146","author":"Li","year":"2024","journal-title":"J Am Chem Soc"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.3c05018","article-title":"MOTAI: A novel method for the study of O-galNAcylation and complex O-glycosylation in cancer","volume":"96","author":"Yue","year":"2024","journal-title":"Anal Chem"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1660852\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T06:31:44Z","timestamp":1764138704000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1660852\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":142,"alternative-id":["10.3389\/fimmu.2025.1660852"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1660852","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"article-number":"1660852"}}